| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Institute of Immunology, School of Medicine,
Institute of Environmental Research, Shandong University, Jinan, People’s Republic of China; and
Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104
Hepatitis B virus (HBV) infection afflicts >300 million people worldwide and is a leading cause of hepatocyte death, cirrhosis, and hepatocellular carcinoma. While the morphological characteristics of dying hepatocytes are well documented, the molecular mechanisms leading to the death of hepatocytes during HBV infection are not well understood. TRAIL, the TNF-related apoptosis-inducing ligand, has recently been implicated in the death of hepatocytes under certain inflammatory but not normal conditions. To determine the potential roles of TRAIL in HBV-induced hepatitis, we examined the effects of HBV and its X protein (HBx) on TRAIL-induced hepatocyte apoptosis both in vivo and in vitro. We found that hepatitis and hepatic cell death in HBV transgenic mice were significantly inhibited by a soluble TRAIL receptor that blocks TRAIL function. We also found that HBV or HBx transfection of a hepatoma cell line significantly increased its sensitivity to TRAIL-induced apoptosis. The increase in TRAIL sensitivity were associated with a dramatic up-regulation of Bax protein expression. Knocking down Bax expression using Bax-specific small interference RNA blocked HBV-induced hepatitis and hepatocyte apoptosis. The degradation of caspases 3 and 9, but not that of Bid or caspase-8, was preferentially affected by Bax knockdown. These results establish that HBV sensitizes hepatocytes to TRAIL-induced apoptosis through Bax and that Bax-specific small interference RNA can be used to inhibit HBV-induced hepatic cell death.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by grants from the Natural Science Foundation of China (30128023, 30440040, and 30371342) and National Education Ministry of China (20030422056).
2 X.L. and Y.L. contributed equally to this work.
3 Address correspondence and reprint requests to Dr. Youhai H. Chen, 614 BRB-II/III, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, 421 Curie Boulevard, Philadelphia, PA 19104; E-mail address: yhc{at}mail.med.upenn.edu or Dr. Wensheng Sun, Institute of Immunology, School of Medicine, Shandong University, Jinan, 250012 People’s Republic of China; E-mail address: wsw{at}sdu.edu.cn
4 Abbreviations used in this paper: HBV, hepatitis B virus; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BH, Bcl-2 homology; DcR, decoy receptor; DR, death receptor; FasL, Fas ligand; sDR5, soluble DR5; siRNA, small interference RNA.
This article has been cited by other articles:
|
|
 |
|
  L. Lan, S. Gorke, S. J. Rau, M. B. Zeisel, E. Hildt, K. Himmelsbach, M. Carvajal-Yepes, R. Huber, T. Wakita, A. Schmitt-Graeff, et al. Hepatitis C Virus Infection Sensitizes Human Hepatocytes to TRAIL-Induced Apoptosis in a Caspase 9-Dependent Manner J. Immunol., October 1, 2008; 181(7): 4926 - 4935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Dunn, M. Brunetto, G. Reynolds, T. Christophides, P. T. Kennedy, P. Lampertico, A. Das, A. R. Lopes, P. Borrow, K. Williams, et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage J. Exp. Med., March 19, 2007; 204(3): 667 - 680. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
